These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral Restenosis. Gasior P; Cheng Y; Valencia AF; McGregor J; Conditt GB; Kaluza GL; Granada JF Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487355 [TBL] [Abstract][Full Text] [Related]
3. Vascular Response of a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) versus a Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) in Healthy Swine Femoropopliteal Arteries. Sakamoto A; Torii S; Jinnouchi H; Fuller D; Cornelissen A; Sato Y; Kuntz S; Mori M; Kawakami R; Kawai K; Fernandez R; Paek KH; Gadhoke N; Guo L; Kolodgie FD; Young B; Ragheb A; Virmani R; Finn AV J Vasc Interv Radiol; 2021 Jun; 32(6):792-801.e5. PubMed ID: 33677117 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions. Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998 [TBL] [Abstract][Full Text] [Related]
5. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries. Sperling C; Waliszewski MW; Kherad B; Krackhardt F Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial. Gouëffic Y; Torsello G; Zeller T; Esposito G; Vermassen F; Hausegger KA; Tepe G; Thieme M; Gschwandtner M; Kahlberg A; Schindewolf M; Sapoval M; Diaz-Cartelle J; Stavroulakis K; Circulation; 2022 Nov; 146(21):1564-1576. PubMed ID: 36254728 [TBL] [Abstract][Full Text] [Related]
7. Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury. Buszman PP; Tellez A; Afari M; Cheng Y; Conditt GB; McGregor JC; Milewski K; Stenoien M; Kaluza GL; Granada JF EuroIntervention; 2013 Aug; 9(4):510-6. PubMed ID: 23965356 [TBL] [Abstract][Full Text] [Related]
8. Temporal Course of Vascular Response After Fluoropolymer Paclitaxel-Eluting Stent Implantation for Femoropopliteal Artery Lesions. Tomoi Y; Kuramitsu S; Shinozaki T; Hiramori S; Soga Y; Ando K Circ J; 2021 Nov; 85(12):2159-2165. PubMed ID: 33716266 [TBL] [Abstract][Full Text] [Related]
9. Angioscopic Assessments at 3 Months After Fluoropolymer-Based Paclitaxel-Eluting Stent Implantation for Femoropopliteal Endovascular Intervention. Tsujimura T; Ishihara T; Iida O; Hata Y; Kurata N; Asai M; Masuda M; Okamoto S; Nanto K; Kanda T; Matsuda Y; Mano T Circ J; 2020 Oct; 84(11):1999-2005. PubMed ID: 32981923 [TBL] [Abstract][Full Text] [Related]
10. Angioscopic Evaluation of Vascular Response After Fluoropolymer-Based Drug-Eluting Stent Implantation for Femoropopliteal Artery Lesions. Tsujimura T; Iida O; Ishihara T; Asai M; Masuda M; Okamoto S; Nanto K; Matsuda Y; Hata Y; Uematsu H; Toyoshima T; Higashino N; Nakao S; Mano T Circ J; 2023 Feb; 87(3):432-429. PubMed ID: 36624062 [TBL] [Abstract][Full Text] [Related]
11. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model. Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel paclitaxel-eluting stent with a bioabsorbable polymeric surface coating in the porcine artery injury model. Ding F; Lu Z; Zou R; Zhang Y; Guo Q; Li S; Yang J Acta Cardiol; 2011 Dec; 66(6):765-72. PubMed ID: 22299388 [TBL] [Abstract][Full Text] [Related]
13. Increased mortality with paclitaxel-eluting stents is driven by lesion length. Mathlouthi A; Yei KS; Naazie I; Bertges DJ; Malas MB J Vasc Surg; 2021 Feb; 73(2):548-553.e2. PubMed ID: 32615286 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and predictors of restenosis in patients with femoropopliteal artery disease treated using polymer-coated paclitaxel-eluting stents or drug-coated balloons. Yoshioka N; Tokuda T; Koyama A; Yamada T; Nishikawa R; Shimamura K; Takagi K; Morita Y; Tanaka A; Ishii H; Morishima I; Murohara T; Heart Vessels; 2022 Apr; 37(4):555-566. PubMed ID: 34553242 [TBL] [Abstract][Full Text] [Related]
20. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]